Preliminary studies on the use of pertussis toxin for the modulation of intravaginal SIV transmission in rhesus macaques.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28940591)

Published in J Med Primatol on September 21, 2017

Authors

Kristina Ortiz1, Rebecca S Sampathkumar2, Aftab A Ansari1, Siddappa N Byrareddy3

Author Affiliations

1: Department of Pathology & Lab Medicine, Emory University School of Medicine, Atlanta, GA, USA.
2: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
3: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198; and.

Articles cited by this

Setting the stage: host invasion by HIV. Nat Rev Immunol (2008) 3.25

Effectiveness of interventions for the prevention of HIV and other sexually transmitted infections in female sex workers in resource poor setting: a systematic review. Trop Med Int Health (2008) 3.03

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis (2000) 2.04

A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunol (2012) 1.40

Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest (2005) 1.32

Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection. Nat Med (2014) 1.32

The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum. AIDS (1993) 1.15

G(i/o) protein-dependent and -independent actions of Pertussis Toxin (PTX). Toxins (Basel) (2011) 1.08

Pharmacology of pertussis toxin B-oligomer. Can J Physiol Pharmacol (1996) 1.08

HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment. Am J Reprod Immunol (2010) 1.05

HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities. Open AIDS J (2016) 0.94

The lymphocytosis-promoting agent pertussis toxin affects virus burden and lymphocyte distribution in the SIV-infected rhesus macaque. AIDS Res Hum Retroviruses (1997) 0.90

Chemokine expression patterns in the systemic and genital tract compartments are associated with HIV-1 infection in women from Benin. J Clin Immunol (2009) 0.89

HIV-1 vaccines: challenges and new perspectives. Hum Vaccin Immunother (2014) 0.89

The Impact of HIV Drug Resistance on the Selection of First- and Second-Line ART in Resource-Limited Settings. J Infect Dis (2013) 0.85

Toward a new vaccine for pertussis. Proc Natl Acad Sci U S A (2014) 0.83

The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells. J Immunol (2001) 0.80